These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38147378)

  • 1. [Nimodipine in treatment of bipolar disorder].
    Romanov DV; Sheyanov AM; Samsonova MD; Iuzbashian PG
    Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(12):20-26. PubMed ID: 38147378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of nimodipine in the treatment of mood disorders.
    Goodnick PJ
    Bipolar Disord; 2000 Sep; 2(3 Pt 1):165-73. PubMed ID: 11256683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nimodipine treatment of an adolescent with ultradian cycling bipolar affective illness.
    Davanzo PA; Krah N; Kleiner J; McCracken J
    J Child Adolesc Psychopharmacol; 1999; 9(1):51-61. PubMed ID: 10357518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic review of calcium channel antagonists in bipolar disorder and some considerations for their future development.
    Cipriani A; Saunders K; Attenburrow MJ; Stefaniak J; Panchal P; Stockton S; Lane TA; Tunbridge EM; Geddes JR; Harrison PJ
    Mol Psychiatry; 2016 Oct; 21(10):1324-32. PubMed ID: 27240535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium channel blocker, nimodipine, for the treatment of bipolar disorder during pregnancy.
    Yingling DR; Utter G; Vengalil S; Mason B
    Am J Obstet Gynecol; 2002 Dec; 187(6):1711-2. PubMed ID: 12501088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bipolar affective disorders and role of intraneuronal calcium. Therapeutic effects of the treatment with lithium salts and/or calcium antagonist in patients with rapid polar inversion].
    Manna V
    Minerva Med; 1991 Nov; 82(11):757-63. PubMed ID: 1766578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nimodipine increases CSF somatostatin in affectively ill patients.
    Pazzaglia PJ; George MS; Post RM; Rubinow DR; Davis CL
    Neuropsychopharmacology; 1995 Aug; 13(1):75-83. PubMed ID: 8526973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid cycling bipolar disease: new concepts and treatments.
    Dubovsky SL
    Curr Psychiatry Rep; 2001 Dec; 3(6):451-62. PubMed ID: 11707158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nimodipine in otolaryngology: from past evidence to clinical perspectives.
    Monzani D; Genovese E; Pini LA; Di Berardino F; Alicandri Ciufelli M; Galeazzi GM; Presutti L
    Acta Otorhinolaryngol Ital; 2015 Jun; 35(3):135-45. PubMed ID: 26246657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary controlled trial of nimodipine in ultra-rapid cycling affective dysregulation.
    Pazzaglia PJ; Post RM; Ketter TA; George MS; Marangell LB
    Psychiatry Res; 1993 Dec; 49(3):257-72. PubMed ID: 8177920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nimodipine Reappraised: An Old Drug With a Future.
    Carlson AP; Hänggi D; Macdonald RL; Shuttleworth CW
    Curr Neuropharmacol; 2020; 18(1):65-82. PubMed ID: 31560289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium channel antagonists for the treatment of bipolar disorder.
    Levy NA; Janicak PG
    Bipolar Disord; 2000 Jun; 2(2):108-19. PubMed ID: 11252650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Calcium antagonists and lithium in preventive treatment of manic-depressive disorder].
    Sarfati Y; Spadone C; Vanelle JM; Lôo H
    Encephale; 1996; 22(2):149-53. PubMed ID: 8706625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nimodipine for primary degenerative, mixed and vascular dementia.
    López-Arrieta ; Birks J
    Cochrane Database Syst Rev; 2001; (1):CD000147. PubMed ID: 11279679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nimodipine, an L-type calcium channel blocker attenuates mitochondrial dysfunctions to protect against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice.
    Singh A; Verma P; Balaji G; Samantaray S; Mohanakumar KP
    Neurochem Int; 2016 Oct; 99():221-232. PubMed ID: 27395789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nimodipine inhibits AP firing in cultured hippocampal neurons predominantly due to block of voltage-dependent potassium channels.
    Caro A; Tarabova B; Rojo-Ruiz J; Lacinova L
    Gen Physiol Biophys; 2011; 30 Spec No():S44-53. PubMed ID: 21869451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nimodipine monotherapy and carbamazepine augmentation in patients with refractory recurrent affective illness.
    Pazzaglia PJ; Post RM; Ketter TA; Callahan AM; Marangell LB; Frye MA; George MS; Kimbrell TA; Leverich GS; Cora-Locatelli G; Luckenbaugh D
    J Clin Psychopharmacol; 1998 Oct; 18(5):404-13. PubMed ID: 9790159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nimodipine, a dihydropyridine-type calcium channel blocker, prevents alcoholic hepatitis caused by chronic intragastric ethanol exposure in the rat.
    Iimuro Y; Ikejima K; Rose ML; Bradford BU; Thurman RG
    Hepatology; 1996 Aug; 24(2):391-7. PubMed ID: 8690410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nimodipine for primary degenerative, mixed and vascular dementia.
    López-Arrieta JM; Birks J
    Cochrane Database Syst Rev; 2002; (3):CD000147. PubMed ID: 12137606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of nimodipine on calcium homeostasis and pain sensitivity in diabetic rats.
    Shutov L; Kruglikov I; Gryshchenko O; Khomula E; Viatchenko-Karpinski V; Belan P; Voitenko N
    Cell Mol Neurobiol; 2006; 26(7-8):1541-57. PubMed ID: 16838100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.